Lyme Disease Support 1 Liquid
NDC Package 66096-722-05
Package Information
Lyme Disease Support 1 (alumen, calcarea carbonica, dna, ferrum phosphoricum, hepar sulphuris calcareum, kali carbonicum, kali muriaticum, kali sulphuricum, magnesia phosphorica, natrum muriaticum, natrum phosphoricum, rna, silicea.) liquids is classified as a
- calculi dissolution agent - [epc] (established pharmacologic class)
- increased large intestinal motility - [pe] (physiologic effect)
- inhibition large intestine fluid/electrolyte absorption - [pe] (physiologic effect)
- inhibition small intestine fluid/electrolyte absorption - [pe] (physiologic effect)
- magnesium ion exchange activity - [moa] (mechanism of action)
- osmotic activity - [moa] (mechanism of action)
- osmotic laxative - [epc] (established pharmacologic class)
- potassium compounds - [cs]
- potassium salt - [epc] (established pharmacologic class)
- stimulation large intestine fluid/electrolyte secretion - [pe] (physiologic effect)
Identification & Billing
Clinical Specifications
- CALCIUM SULFIDE 6 [hp_X]/59mL
- FERROSOFERRIC PHOSPHATE 6 [hp_X]/59mL
- HERRING SPERM DNA 4 [hp_C]/59mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 6 [hp_X]/59mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 6 [hp_X]/59mL
- POTASSIUM ALUM 12 [hp_X]/59mL
- POTASSIUM CARBONATE 6 [hp_X]/59mL
- POTASSIUM CHLORIDE 6 [hp_X]/59mL
- POTASSIUM SULFATE 6 [hp_X]/59mL
- SACCHAROMYCES CEREVISIAE RNA 4 [hp_C]/59mL
- SILICON DIOXIDE 12 [hp_X]/59mL
- SODIUM CHLORIDE 6 [hp_X]/59mL
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 6 [hp_X]/59mL
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 66096 - Ohm Pharma Inc.
- 66096-722 - Lyme Disease Support 1
- 66096-722-05 - 59 mL in 1 BOTTLE, DROPPER
- 66096-722 - Lyme Disease Support 1
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 66096-722-05 identifies a specific commercial package of 59 ml in 1 bottle, dropper of Lyme Disease Support 1, a human over the counter drug labeled by Ohm Pharma Inc.. This liquid is formulated for oral use and contains calcium sulfide; ferrosoferric phosphate; herring sperm dna; magnesium phosphate, dibasic trihydrate; oyster shell calcium carbonate, crude; potassium alum; potassium carbonate; potassium chloride; potassium sulfate; saccharomyces cerevisiae rna; silicon dioxide; sodium chloride; sodium phosphate, dibasic, heptahydrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ohm Pharma Inc. on November 20, 2017. The current certification is valid through December 31, 2026.
How is this Ohm Pharma Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 66096072205. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.